The Protocol for the PHAST-TRAC study is now available for download here. Update: The recruitment for PHAST TRAC trial has finished.
Yearly Archives: 2016
Manchester, England, 1 September 2016 – Nestlé Health Science (NHSc) and Phagenesis announced today that NHSc is entering into a staged, milestone-based acquisition of Phagenesis, a medical device company that has developed a new treatment for dysphagia. Under the terms … Continue reading